Published in Level 2 journals, first or last author from Oslo University Hospital.
Gjelsvik YM, Myklebust TÅ, Fosså SD, Haug ES, Kvåle R, Ursin G, Johannesen TB(2025) A nationwide, longitudinal collection of patient-reported outcomes from prostate cancer patients and controls Qual Life Res(in press) DOI 10.1007/s11136-025-04017-7, PubMed 40603678
Fleur du Pré M, Kleppa L, Dewan AE, Meling MT, Høydahl LS, Besser HA, Khosla C, Sollid LM(2025) Peyer's patch B cells sample transglutaminase-gluten complexes and drive celiac disease autoimmunity Gastroenterology(in press) DOI 10.1053/j.gastro.2025.06.021, PubMed 40602545
Lindemann K, Berton D, Sehouli J, Christensen RD, Altintas S, Knudsen AØ, Heudel PE, Ataseven B, Vergote I, Lindahl G, Lebreton C, Schochter F, Auranen A, Follana P, Madsen K, Selle F, Petersson KS, Joly F, Braicu EI, Mirza MR(2025) NSGO-FANDANGO/ENGOT-EN1: A randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer Gynecol Oncol, 199, 79-87(in press) DOI 10.1016/j.ygyno.2025.06.008, PubMed 40592025
